Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.

Sensex jumps 639 points, Nifty reclaims 24,100 as Reliance Industries, Sun Pharma lead rebound
BSE Sensex and NSE Nifty rebounded after three losing sessions, led by Sun Pharma, Reliance Industries and midcaps, with all sectoral indices ending higher
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.

Holding 10 or more mutual funds? You may be over-diversified — here’s the ideal number
While there is no magical number, most wealth advisors and financial planners that Mint talked to recommended that 4-6 funds spread across asset classes and stock categories can take care of the majority of the needs of an investor.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade

Max Healthcare to acquire controlling stake in Kalinga Hospital for ₹300 crore
Max Healthcare to buy 58.4% of Kalinga Hospital for ₹300 crore, entering Bhubaneswar, will fund via external borrowings and lend ₹100 crore for upgrades
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
India gains favour with global investors on returns, ESG momentum
India is maturing as a market in which foreign investors who take into account environmental, social and governance (ESG) factors are confident in dedicating more of their portfolio to, according to fund managers at the Indian Venture and Alternate Capital Association conclave in Mumbai, who cite the economy's scale, improving return outlook and advancing ESG standards as key differentiators.
Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Equitymaster
Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4%Equitymaster
Today's Market: Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Indian Stock Market News - Equitymaster
Today's Market: Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Indian Stock Market NewsEquitymaster

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.